Antyoksydanty a choroby osrodkowego ukladu nerwowego

• Autorzy: Borawska M H , Konopka M.

Warianty tytułu

EN

Antioxidants and diseases of the central nervous system

• Języki publikacji: PL

Abstrakty

PL

W pracy omówiono udział reaktywnych form tlenu i reaktywnych form azotu w powstawaniu najczęściej /stępujących chorób neurodegeneracyjnych ośrodkowego układu nerwowego; choroby Alzheimera i choroby Sona. Wykazano, że dieta bogata w naturalne antyoksydanty, z dużą ilością świeżych warzyw i owoców pobiega chorobom neurodegeneracyjnym i wydłuża życie.

EN

This work presents participation reactive oxygen species and reactive nitrogen species in creation of the most often appearing neurodegeneration diseases of central nervous system; Alzheimer's disease and Parkinsons's disease. It exerts that diet rich with natural antioxidants, with big amount of fresh vegetables and fruits prevents neurodegeneration diseases and prolongs life.

Słowa kluczowe

PL

choroba Parkinsona; warzywa swieze; uklad nerwowy osrodkowy; choroba Alzheimera; dieta; ludzie starzy; przeciwutleniacze; zalecenia zywieniowe; choroby czlowieka; spozycie zywnosci; choroby neurodegeneracyjne; choroby ukladu nerwowego; owoce swieze; zywienie czlowieka

• Wydawca: -
• Czasopismo: Żywienie Człowieka i Metabolizm
• Rocznik: 2007
• Tom: 34
• Numer: 1-2
• Opis fizyczny: s.41-45,bibliogr.

Twórcy

autor

Borawska M H

• Akademia Medyczna, Bialystok

autor

Konopka M.

Bibliografia

• 1. Anekonda T.S., Reddy P.H.: Neuronal protection by sirtuins in Alzheimer's disease. J. Neurochem., 2006, 96, 305.
• 2. Araki T., Sasaki Y., Milbrandt J.: Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration. Science, 2004, 305, 1010.
• 3. Bordone L., Guarente L., Calorie restriction, SIRT1 and metabolism: understanding longevity. Nat. Rev. Mol. Cell Biol., 2005, 6, 298.
• 4. Borra M.T., Smith B.C., Denu J.M.: Mechanism of human SIRT1 activation by resveratrol. J. Biol. Chem., 2005, 280, 17187.
• 5. Butterfield D.A., Castegna A., Lauderback C.M., Drake J.: Evidence that amyloid beta peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contribute to neuronal death. Neurobiol. Aging, 2002, 23, 655.
• 6. Cadenas E., Davies K.J.A.: Mitochondrial free radical generation, oxidative stress, and aging. Free Radical Bio. Med., 2000, 29, 222.
• 7. Cuajungco M.P., Faget K.Y.: Zinc takes the center stage: its paradoxical role in Alzheimer's disease. Brain Res. Rev., 2003, 41(1), 44.
• 8. Cuajungco M.P., Goldstein L.E., Nunomura A., Smith M.A., Lim J.T., Atwood C.S., Huang X., Farrag Y.W., Perry G., Bush A.J.: Evidence that the beta-amyloid plaques of Alzheimer's disease represent the redox-silencing and entombment of A beta by zinc. J. Bio. Chem., 2000, 275, 19439.
• 9. Dai Q., Borenstein A.R., Wu Y., Jackson J.C., Larson E.B.: Fruit and vegetable juices and Alzheimer's disease: The Karne Project. Am. J. Med., 2006, 119(9), 751.
• 10. Dalle-Donne I., Rossi R., Colombo R., Giustarini D., Milzani A.: Biomarkers of oxidative damage in human disease. Clin. Chem., 2006, 52, 601.
• 11. Dikalov S I.,Vite M., Mason R.P.: Cupric-amyloid beta peptide complex stimulates oxidation of ascorbate and generation of hydroxyl radical. Free Radical Bio. Med., 2004, 36, 340.
• 12. Etminan M., Gill S.S., Samii A.: Intake of vitamin E, vitamin C, and carotenoids and the risk of Parkinson's disease: a meta-analysis. Lancet Neurol. 2005, 4(6), 362.
• 13. Fariss M.W., Zhang J.G.:Vitamin E therapy in Parkinson's disease. Toxicology, 2003, 189(1-2), 129.
• 14. Ishige K., Schubert D., Sagara Y.: Flavonoids protect neuronal cells from oxidative stress by three distinct mechanisms. Free Radical Bio. Med., 2001, 30(4), 433.
• 15. Kaur D., Yantiri F., Rajagopalan S., Kumar J., Mo J. O., Boonplueang R., Viswanath V., Jacobs R., Yang L., Beal M.F., DiMonte D., Volitaskis I., Ellerby L„ Cherny R.A.,. Bush A., Andersen J.K.: Genetic or pharmacological iron chelation prevents MPTP- induced neurotoxicity in vivo: a novel therapy for Parkinson's disease. Neuron, 2003, 37, 899.
• 16. Laurin D., Masaki K.H., Foley D.J., White L.R., Launer L.J.: Midlife dietary intake of antioxidants and risk of late-life incident dementia: the Honolulu-Asia Aging Study. Am. J. Epidemiol., 2004, 159(10), 959.
• 17. O'Byrne D.J., Devaraj S., Grundy S.M., Jialal I.: Comparison of the antioxidant effects of Concord grape juice flavonoids alpha-tocopherol on markers of oxidative stress in healthy adults. Am. J. Clin. Nutr., 2002, 76(6), 1367.
• 18. Oken B.S., Storzbach D.M., Kaye J.A.: The efficacy of Ginkgo biloba on cognitive function in Alzheimer disease. Arch. Neurol., 1998, 55, 1409.
• 19. Opii W.O., Joshi G., Head E., Milgram N.W., Müggenburg B.A., Klein J.B., Pierce W.M., Cotman C.W., Butterfield D.A.: Proteomic identification of brain proteins in the canine model of human aging following a long-term treatment with antioxidants and a program of behavioral enrichment: Relevance to j Alzheimer's disease. Neurobiol. Aging, 2006, 19, [Epub ahead of print],
• 20. Orgogozo J.M., I Dartigues J.F., Lafont S., Letenneur L., Commenges D., Salamon R., Renaud S., Breteler I M.B.: Wine consumption and dementia in the elderly: a prospective community study in the ; Bordeaux area. Rev. Neurol., 1997, 153, 185.
• 21. Ortiz D., Shea T.B.: Apple juice prevents oxidative stress induced by amyloid- beta in culture. J. Alzheimers Dis., 2004, 6(1)27.
• 22. Patii C.S., Singh V.P., Satyanarayan ; P.S., Jain N.K., Singh A., Kulkami S.K.: Protective effect of flavonoids against aging- and lipopolysaccharide-induced cognitive impairment in mice. Pharmacology, 2003, 69(2), 59.
• 23. Perry G., Cash A.D., Smith M.A.: Alzheimer disease and oxidative stress. J. Biomed. Biotechnol., 2002, 2(3), 120.
• 24. Pham D.Q., Plakogiannis R.: Vitamin E supplementation in Alzheimer's disease, Parkinson's disease, tardive dyskinesia, and cataract: Part 2. Ann. Pharmacother., 2005, 39(12), 2065.
• 25. Prusiński A.: Neurologia praktyczna, Warszawa, i PZWL, 1998.
• 26. Sanchez-Moreno C,. Cano M.P., de Ancos B., Plaza L., Olmedilla B., Granado F., Martín A.: High-pressurized orange juice consumption affects plasma vitamin C, antioxidative status and inflammatory markers in healthy humans. J. Nutr., 2003, 133(7), 2204.
• 27. Sano M., Ernesto C., Thomas R.G., Klauber M.R., Schafer K., Grundman M., Woodbury P., Growdon J., Pfeiffer E., Schneider L.S., Thal L.J.: A controlled trial of selegiline, alfa-tocopherol or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study. N. Engl. J. Med., 1997, 336, 1216.
• 28. Sayre L.M., Smith M.A., Perry G.: Chemistry and biochemistry of oxidative stress in neurodegenerative disease. Curr. Med. Chem., 2001, 8, 721.
• 29. Sinclair D.A.: Toward a unified theory of caloric restriction and longevity regulation. Mech. Ageing Dev., 2005, 126. 987.
• 30. Stohs S.J., Bagchi D.: Oxidative mechanisms in the toxicity of metal ions. Free Radical Bio. Med., 1995, 18, 321.
• 31. Tamagno E., Bardini P., Guglielmotto M., Danni O., Tabaton M.: The various aggregation states of ß-amyloid 1-42 mediate different effects on oxidative stress, neurodegeneration, and BACE-1 expression. Free Radical Bio. Med., 2006, 41, 202.
• 32. United Nations Ponulation Division: World Population Prospect. The 2002 Revision. ESA/P/WP. 180, 2003.
• 33. Vatassery G.T., Bauer T., Dysken M.: High doses of vitamin E in the treatment of disorders of the central nervous system in the aged. Am. J. Clin. Nutr., 1999, 70, 793.
• 34. Zhuang H., Kim Y.S., Koehler R.C., Dore S.: Potential mechanism by which resveratrol, a red wine constituent, protects neurons. Ann. N. Y. Acad. Sei., 2003, 993, 276.